Treatment of stress incontinence with estrogen in postmenopausal women.
41 female patients with a stress incontinence of grade II or III were treated with 2 mg estriol daily over a period of 2-4 months. The function of the bladder was objectively evaluated by urethrocystotonometry. A significant rise of the urethral pressure profile could be demonstrated in 95% (39/41) of patients. An improvement of the stress incontinence by one clinical grade could be shown, but in no case a completely continent bladder sphincter.
D004964:Estriol / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008593:Menopause; D014521:Urethra / Q000187:drug effects; D014550:Urinary Incontinence, Stress / Q000188:drug therapy*
D004964:Estriol